Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Bioceres Crop Solutions (BIOX) Cost of Revenue (2016 - 2026)

Bioceres Crop Solutions' Cost of Revenue history spans 5 years, with the latest figure at $26.7 million for Q1 2026.

  • On a quarterly basis, Cost of Revenue fell 19.09% to $26.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $69.8 million, a 0.17% change, with the full-year FY2025 number at $203.4 million, down 26.88% from a year prior.
  • Cost of Revenue hit $26.7 million in Q1 2026 for Bioceres Crop Solutions, down from $33.0 million in the prior quarter.
  • Over the last five years, Cost of Revenue for BIOX hit a ceiling of $33.0 million in Q1 2025 and a floor of $5.3 million in Q2 2022.
  • Historically, Cost of Revenue has averaged $21.7 million across 3 years, with a median of $26.7 million in 2026.
  • Biggest five-year swings in Cost of Revenue: rose 9.09% in 2022 and later decreased 19.09% in 2026.
  • Tracing BIOX's Cost of Revenue over 3 years: stood at $5.3 million in 2022, then surged by 526.3% to $33.0 million in 2025, then decreased by 19.09% to $26.7 million in 2026.
  • Business Quant data shows Cost of Revenue for BIOX at $26.7 million in Q1 2026, $33.0 million in Q1 2025, and $5.3 million in Q2 2022.